Home > NRC Library > ADAMS Public Documents

Zevacor Pharma, Inc. d/b/a Zevacor, License No. 45-25221-05.

Accession Number: ML16097A589

Date Released: Wednesday, April 13, 2016

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML16097A569 - Cover Letter for Zevacor Pharma, Inc. d/b/a Zevacor, License No. 45-25221-05. (2 page(s), 4/1/2016)
• ML16004A315 - IBA Molecular North America, Inc., License No. 45-25221-05. (2 page(s), 12/17/2015)
• ML15222A413 - IBA Molecular North America, Inc., Safety Evaluation Report dated July 15, 2015. (3 page(s), 7/15/2015)
• ML15222A371 - IBA Molecular North America, Inc., Transfer of Control, Control No. 586861/586771. (3 page(s), 7/15/2015)